ACM
MIRM icon

ADAR1 Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

ADAR1 Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$457K Sell
3,900
-2,300
-37% -$231K 0.02% 218
2026
Q1 		$573K Buy
+6,200
New +$583K 0.03% 196
2024
Q4 		– Sell
-24,100
Closed -$940K – 270
2024
Q3 		$940K Buy
+24,100
New +$961K 0.15% 82

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ADAR1 Capital Management's MIRM Position: Q2 2026 in Review

ADAR1 Capital Management reduced its Mirum Pharmaceuticals (MIRM) stake by 37% in Q2 2026, selling an estimated $231K and leaving 3,900 shares worth $457K. The position accounts for 0.02% of the portfolio, ranked #218.

ADAR1 Capital Management first reported a position in MIRM in Q3 2024 and has held it in 3 quarters since. The position peaked at $940K in Q3 2024. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • ADAR1 Capital Management held 3,900 shares of Mirum Pharmaceuticals worth $457K as of Q2 2026.
  • ADAR1 Capital Management sold 2,300 Mirum Pharmaceuticals shares in Q2 2026, an estimated $231K.
  • Mirum Pharmaceuticals made up 0.02% of ADAR1 Capital Management's portfolio in Q2 2026, its #218 holding.
  • ADAR1 Capital Management first reported a position in Mirum Pharmaceuticals in Q3 2024 and has held it in 3 quarters since.
  • ADAR1 Capital Management's Mirum Pharmaceuticals position peaked at $940K in Q3 2024.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.